COCP vs JCI · rev $105.0K vs P/E 44, rev $23.60B
Cocrystal Pharma Inc (COCP) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Cocrystal Pharma Inc (COCP) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported COCP revenue for 2026-06-30 was $105.0K. Net income was -$3.2M. Revenue was down 53.3% from 2026-03-31 to 2026-06-30. COCP currently screens at market cap $13.3M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
COCP currently screens at market cap $13.3M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the COCP and JCI stock pages for the full models.
Not investment advice.